The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study
- PMID: 11197248
- DOI: 10.1111/j.1572-0241.2001.03469.x
The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study
Abstract
Objectives: Although symptomatic propylthiouracil (PTU)-induced hepatic injury is known to be rare, there have been few reports about its exact incidence in patients with hyperthyroidism. We tried to evaluate its incidence in a single center and its clinical course.
Methods: Medical records of 912 hyperthyroid patients who had been diagnosed between March 1990 and December 1998 were reviewed about clinical characteristics, management, and laboratory findings. Symptomatic PTU-induced hepatic injury was defined as the development of jaundice or hepatitis symptoms with at least a 3-times elevation of liver function tests (LFT) without other causes.
Results: Four hundred ninety-seven patients (age 42.6 +/- 10.7 yr, male/female 140/357) were included. Clinically overt hepatitis developed in six patients (1.2%; age, 43.7 +/- 14.8 yr; male:female ratio, 3:3) between 12 and 49 days after PTU administration. Jaundice and itching developed in five patients, fever in two, rash in two, and arthralgia in one. Bilirubin, ALT, and ALP increased in five, four, and six patients, respectively (293 +/- 288 micromol/L, 143 +/- 111 U/L, and 265 +/- 81 U/L; normal, < 117 U/L). The type of hepatic injury was cholestatic in three, hepatocellular in one, and mixed in two patients. None resulted from viral hepatitis. There were no statistical differences in age, sex, PTU dose, or T4 and T3 levels at initial diagnosis between patients with and without hepatic injury. LFT normalized in all patients between 16 and 145 (72.8 +/- 46.4) days after the PTU withdrawal.
Conclusions: Symptomatic hepatic injury develops usually within the first few months of PTU administration with rare frequency, but its clinical course is relatively benign once the drug is withdrawn. However, it may be difficult to predict its development, so all patients should be monitored for rise in LFTs at regular intervals, especially during the early period.
Similar articles
-
[The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):442-6. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15312442 Chinese.
-
[Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Apr;26(2):172-7. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15171556 Chinese.
-
Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.Mater Med Pol. 1996 Jul-Sep;28(3):103-6. Mater Med Pol. 1996. PMID: 9167420 Clinical Trial.
-
[Asymptomatic hepatitis induced by propylthiouracil].Acta Med Port. 2001 Sep-Dec;14(5-6):523-7. Acta Med Port. 2001. PMID: 11878166 Review. Portuguese.
-
Propylthiouracil-induced severe hepatitis: a case report and review of the literature.J Gastroenterol. 1998 Oct;33(5):747-50. doi: 10.1007/s005350050167. J Gastroenterol. 1998. PMID: 9773944 Review.
Cited by
-
Factors affecting drug-induced liver injury: antithyroid drugs as instances.Clin Mol Hepatol. 2014 Sep;20(3):237-48. doi: 10.3350/cmh.2014.20.3.237. Epub 2014 Sep 25. Clin Mol Hepatol. 2014. PMID: 25320726 Free PMC article. Review.
-
Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: A meta-analysis.PLoS One. 2022 Mar 10;17(3):e0265085. doi: 10.1371/journal.pone.0265085. eCollection 2022. PLoS One. 2022. PMID: 35271661 Free PMC article.
-
A Case of Propylthiouracil-Induced Hepatitis during Pregnancy.Eur Thyroid J. 2012 Apr;1(1):41-4. doi: 10.1159/000336071. Epub 2012 Feb 29. Eur Thyroid J. 2012. PMID: 24782996 Free PMC article.
-
Hyperthyroidism.Lancet. 2016 Aug 27;388(10047):906-918. doi: 10.1016/S0140-6736(16)00278-6. Epub 2016 Mar 30. Lancet. 2016. PMID: 27038492 Free PMC article. Review.
-
Propylthiouracyl-induced severe liver toxicity: an indication for alanine aminotransferase monitoring?World J Gastroenterol. 2006 Oct 14;12(38):6232-4. doi: 10.3748/wjg.v12.i38.6232. World J Gastroenterol. 2006. PMID: 17036403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical